Dissociation of ketamine effects on rule acquisition and rule implementation: possible relevance to NMDA receptor contributions to executive cognitive functions - PubMed (original) (raw)
Dissociation of ketamine effects on rule acquisition and rule implementation: possible relevance to NMDA receptor contributions to executive cognitive functions
J H Krystal et al. Biol Psychiatry. 2000.
Abstract
Background: The demands of the Wisconsin Card Sorting Test (WCST) change with experience. This report contains two studies designed to examine N-methyl-D-aspartate (NMDA) receptor contributions to the executive components of WCST performance. These aspects of WCST performance figure more prominently in the initial completion of this task than in subsequent task repetitions in healthy populations.
Methods: In the first study, healthy subjects (n = 15) completed the WCST on two occasions separated by 1 week. In the second study, healthy subjects (n = 22) completed two test days spaced by approximately 1 week, during which, they completed the WCST and other assessments after administration of the NMDA antagonist ketamine (intravenous bolus 0.26 mg/kg followed by infusion of 0.65 mg/kg/hour) or matched placebo.
Results: In the first study, subjects reduced the number of total and perseverative errors with a single repetition of the WCST. In the second study, ketamine significantly increased the number of total errors and the number and percent of perseverative errors on the first, but not the second test day. Similarly, it reduced the number of category criteria met on the first, but not second test day. Ketamine also increased distractibility, impaired recall, produced psychosis, altered perception, and had effects resembling the negative symptoms of schizophrenia. However, only WCST performance showed order dependency.
Conclusions: This order dependency further implicates NMDA receptors in executive cognitive functions associated with the frontal cortex.
Similar articles
- Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans.
Krystal JH, Karper LP, Bennett A, D'Souza DC, Abi-Dargham A, Morrissey K, Abi-Saab D, Bremner JD, Bowers MB Jr, Suckow RF, Stetson P, Heninger GR, Charney DS. Krystal JH, et al. Psychopharmacology (Berl). 1998 Feb;135(3):213-29. doi: 10.1007/s002130050503. Psychopharmacology (Berl). 1998. PMID: 9498724 Clinical Trial. - Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.
Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, Heninger GR, Bowers MB Jr, Charney DS. Krystal JH, et al. Arch Gen Psychiatry. 1994 Mar;51(3):199-214. doi: 10.1001/archpsyc.1994.03950030035004. Arch Gen Psychiatry. 1994. PMID: 8122957 Clinical Trial. - Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists.
Anand A, Charney DS, Oren DA, Berman RM, Hu XS, Cappiello A, Krystal JH. Anand A, et al. Arch Gen Psychiatry. 2000 Mar;57(3):270-6. doi: 10.1001/archpsyc.57.3.270. Arch Gen Psychiatry. 2000. PMID: 10711913 Clinical Trial. - [Glutaminergic hypothesis of schizophrenia: clinical research studies with ketamine].
Mechri A, Saoud M, Khiari G, d'Amato T, Dalery J, Gaha L. Mechri A, et al. Encephale. 2001 Jan-Feb;27(1):53-9. Encephale. 2001. PMID: 11294039 Review. French. - Effects of ketamine on psychomotor, sensory and cognitive functions relevant for driving ability.
Giorgetti R, Marcotulli D, Tagliabracci A, Schifano F. Giorgetti R, et al. Forensic Sci Int. 2015 Jul;252:127-42. doi: 10.1016/j.forsciint.2015.04.024. Epub 2015 Apr 27. Forensic Sci Int. 2015. PMID: 25981945 Review.
Cited by
- Thinking glutamatergically: changing concepts of schizophrenia based upon changing neurochemical models.
Kantrowitz JT, Javitt DC. Kantrowitz JT, et al. Clin Schizophr Relat Psychoses. 2010 Oct;4(3):189-200. doi: 10.3371/CSRP.4.3.6. Clin Schizophr Relat Psychoses. 2010. PMID: 20880830 Free PMC article. Review. - Interaction of N-methyl-D-aspartate and group 5 metabotropic glutamate receptors on behavioral flexibility using a novel operant set-shift paradigm.
Darrah JM, Stefani MR, Moghaddam B. Darrah JM, et al. Behav Pharmacol. 2008 May;19(3):225-34. doi: 10.1097/FBP.0b013e3282feb0ac. Behav Pharmacol. 2008. PMID: 18469540 Free PMC article. - Chronic administration of ketamine mimics the perturbed sense of body ownership associated with schizophrenia.
Tang J, Morgan HL, Liao Y, Corlett PR, Wang D, Li H, Tang Y, Chen J, Liu T, Hao W, Fletcher PC, Chen X. Tang J, et al. Psychopharmacology (Berl). 2015 May;232(9):1515-26. doi: 10.1007/s00213-014-3782-0. Epub 2014 Nov 19. Psychopharmacology (Berl). 2015. PMID: 25404087 - The impact of NMDA receptor blockade on human working memory-related prefrontal function and connectivity.
Driesen NR, McCarthy G, Bhagwagar Z, Bloch MH, Calhoun VD, D'Souza DC, Gueorguieva R, He G, Leung HC, Ramani R, Anticevic A, Suckow RF, Morgan PT, Krystal JH. Driesen NR, et al. Neuropsychopharmacology. 2013 Dec;38(13):2613-22. doi: 10.1038/npp.2013.170. Epub 2013 Jul 16. Neuropsychopharmacology. 2013. PMID: 23856634 Free PMC article. - Targeting metabotropic glutamate receptors for treatment of the cognitive symptoms of schizophrenia.
Moghaddam B. Moghaddam B. Psychopharmacology (Berl). 2004 Jun;174(1):39-44. doi: 10.1007/s00213-004-1792-z. Epub 2004 Feb 19. Psychopharmacology (Berl). 2004. PMID: 15205877 Review.
References
- Anderson SW, Demasio H, Jones RD, Tranel D (1991): Wisconsin Card Sorting Test performance as a measure of frontal lobe damage. J Clin Exp Neuropsychol 13:909–922. - PubMed
- Berman KF, Torrey EF, Daniel DG, Weinberger DR (1992): Regional cerebral blood flow in monozygotic twins discordant and concordant for schizophrenia. Arch Gen Psychiatry 49:927–934. - PubMed
- Berman KF, Zec RF, Weinberger DR (1986): Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia, II: role of neuroleptic treatment, attention, and mental effort. Arch Gen Psychiatry 43:126–135. - PubMed
- Bowers MB, Heninger GR, Sternberg D, Meltzer HY (1980): Clinical processes and central dopaminergic activity in psychotic disorders. Comm Psychopharmacol 4:177–188. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous